Correlation Between Franklin Genomic and Invesco MSCI

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Franklin Genomic and Invesco MSCI at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Franklin Genomic and Invesco MSCI into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Franklin Genomic Advancements and Invesco MSCI Sustainable, you can compare the effects of market volatilities on Franklin Genomic and Invesco MSCI and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Franklin Genomic with a short position of Invesco MSCI. Check out your portfolio center. Please also check ongoing floating volatility patterns of Franklin Genomic and Invesco MSCI.

Diversification Opportunities for Franklin Genomic and Invesco MSCI

0.39
  Correlation Coefficient

Weak diversification

The 3 months correlation between Franklin and Invesco is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Franklin Genomic Advancements and Invesco MSCI Sustainable in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Invesco MSCI Sustainable and Franklin Genomic is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Franklin Genomic Advancements are associated (or correlated) with Invesco MSCI. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Invesco MSCI Sustainable has no effect on the direction of Franklin Genomic i.e., Franklin Genomic and Invesco MSCI go up and down completely randomly.

Pair Corralation between Franklin Genomic and Invesco MSCI

Given the investment horizon of 90 days Franklin Genomic Advancements is expected to generate 0.83 times more return on investment than Invesco MSCI. However, Franklin Genomic Advancements is 1.2 times less risky than Invesco MSCI. It trades about 0.01 of its potential returns per unit of risk. Invesco MSCI Sustainable is currently generating about -0.02 per unit of risk. If you would invest  3,074  in Franklin Genomic Advancements on September 2, 2024 and sell it today you would earn a total of  27.00  from holding Franklin Genomic Advancements or generate 0.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Franklin Genomic Advancements  vs.  Invesco MSCI Sustainable

 Performance 
       Timeline  
Franklin Genomic Adv 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Franklin Genomic Advancements has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong essential indicators, Franklin Genomic is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Invesco MSCI Sustainable 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Invesco MSCI Sustainable are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong basic indicators, Invesco MSCI is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Franklin Genomic and Invesco MSCI Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Franklin Genomic and Invesco MSCI

The main advantage of trading using opposite Franklin Genomic and Invesco MSCI positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Franklin Genomic position performs unexpectedly, Invesco MSCI can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Invesco MSCI will offset losses from the drop in Invesco MSCI's long position.
The idea behind Franklin Genomic Advancements and Invesco MSCI Sustainable pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format